Herbert J Conrad - Net Worth and Insider Trading
Herbert J Conrad Net Worth
The estimated net worth of Herbert J Conrad is at least $307,624 dollars as of 2024-09-20. Herbert J Conrad is the Director of Matinas BioPharma Holdings Inc and owns about 81,598 shares of Matinas BioPharma Holdings Inc (MTNB) stock worth over $307,624. Details can be seen in Herbert J Conrad's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Herbert J Conrad has not made any transactions after 2019-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Herbert J Conrad
Herbert J Conrad Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Herbert J Conrad owns 3 companies in total, including Matinas BioPharma Holdings Inc (MTNB) , Celldex Therapeutics Inc (CLDX) , and Arbutus Biopharma Corp (ABUS) .
Click here to see the complete history of Herbert J Conrad’s form 4 insider trades.
Insider Ownership Summary of Herbert J Conrad
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MTNB | Matinas BioPharma Holdings Inc | 2019-05-16 | director |
| CLDX | Celldex Therapeutics Inc | 2008-03-07 | director |
| ABUS | Arbutus Biopharma Corp | 2015-03-30 | director |
Herbert J Conrad Latest Holdings Summary
Herbert J Conrad currently owns a total of 1 stock. Herbert J Conrad owns 81,598 shares of Matinas BioPharma Holdings Inc (MTNB) as of May 16, 2019, with a value of $307,624.
Latest Holdings of Herbert J Conrad
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MTNB | Matinas BioPharma Holdings Inc | 2019-05-16 | 81,598 | 3.77 | 307,624 |
Holding Weightings of Herbert J Conrad
Herbert J Conrad Form 4 Trading Tracker
According to the SEC Form 4 filings, Herbert J Conrad has made a total of 0 transactions in Matinas BioPharma Holdings Inc (MTNB) over the past 5 years. The most-recent trade in Matinas BioPharma Holdings Inc is the acquisition of 500 shares on May 16, 2019, which cost Herbert J Conrad around $24,000.
Insider Trading History of Herbert J Conrad
- 1
Herbert J Conrad Trading Performance
GuruFocus tracks the stock performance after each of Herbert J Conrad's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Herbert J Conrad is -12.04%. GuruFocus also compares Herbert J Conrad's trading performance to market benchmark return within the same time period. The performance of stocks bought by Herbert J Conrad within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Herbert J Conrad's insider trading performs compared to the benchmark.
Performance of Herbert J Conrad
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.18 | | | | | |
| Relative Return to S&P 500(%) | -10.07 | | | | | |
Herbert J Conrad Ownership Network
Herbert J Conrad Owned Company Details
What does Matinas BioPharma Holdings Inc do?
Who are the key executives at Matinas BioPharma Holdings Inc?
Herbert J Conrad is the director of Matinas BioPharma Holdings Inc. Other key executives at Matinas BioPharma Holdings Inc include Chief Business Officer Thomas Hoover , director & Chief Executive Officer Jerome D Jabbour , and Chief Financial Officer Keith A Kucinski .
Matinas BioPharma Holdings Inc (MTNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Matinas BioPharma Holdings Inc (MTNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Matinas BioPharma Holdings Inc (MTNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Matinas BioPharma Holdings Inc (MTNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Matinas BioPharma Holdings Inc Insider Transactions
Herbert J Conrad Mailing Address
Above is the net worth, insider trading, and ownership report for Herbert J Conrad. You might contact Herbert J Conrad via mailing address: C/o Arbutus Biopharma Corp., 100-8900 Glenlyon Parkway, Burnaby A1 V5j 5j8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
